Introducing Access-2-Healthacare, providing consulting and education for small / medium sized medical technology companies for market entry to various countries, business due diligence, quality, regulatory, trade
Access 2-healthcare , Company Introduction Deck - English - Aug 2017Access-2-Healthcare
Access-2-Healthacare helps small / medium sized medical technology companies gain market entry to various countries, business due diligence, quality, regulatory approvals, trade compliance, software testing, business partnership, product commercialisation
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
Finding insights for our clients is our passion. The world is changing. In a world moving so quickly…. It’s easy to fall behind.
CoreData Research provides both business-to-business and business-to-consumer research, while the group’s offering includes market intelligence, guidance on strategic positioning, methods for developing new business, advice on operational marketing and other consulting services.
Our ability to produce tailored research that speaks to a client’s particular need is flexible and broad yet retains a specialist focus.
RDGInsights & Retail Doctor Group Corporate ProfileThe Retail Doctor
Retail Doctor Group is one of Australia's leading retail consulting companies with expertise in insights, strategy and implementation.
Founded in 2005, we have since worked with over 400 clients to plan and build fit business structures that achieve operational excellence and sustainable profitability.
RDG Insights is RDG’s consumer insights division, specialising in neuromarketing insights, consumer profiling and strategic brand management
We specialise in providing retailers and brands with the missing link between understanding the real drivers of consumer behaviour, brand strategy and operational implications at the point of sale.
Access 2-healthcare , Company Introduction Deck - English - Aug 2017Access-2-Healthcare
Access-2-Healthacare helps small / medium sized medical technology companies gain market entry to various countries, business due diligence, quality, regulatory approvals, trade compliance, software testing, business partnership, product commercialisation
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
Finding insights for our clients is our passion. The world is changing. In a world moving so quickly…. It’s easy to fall behind.
CoreData Research provides both business-to-business and business-to-consumer research, while the group’s offering includes market intelligence, guidance on strategic positioning, methods for developing new business, advice on operational marketing and other consulting services.
Our ability to produce tailored research that speaks to a client’s particular need is flexible and broad yet retains a specialist focus.
RDGInsights & Retail Doctor Group Corporate ProfileThe Retail Doctor
Retail Doctor Group is one of Australia's leading retail consulting companies with expertise in insights, strategy and implementation.
Founded in 2005, we have since worked with over 400 clients to plan and build fit business structures that achieve operational excellence and sustainable profitability.
RDG Insights is RDG’s consumer insights division, specialising in neuromarketing insights, consumer profiling and strategic brand management
We specialise in providing retailers and brands with the missing link between understanding the real drivers of consumer behaviour, brand strategy and operational implications at the point of sale.
Finding insights for our clients is our passion. The world is changing. In a world moving so quickly…. It’s easy to fall behind.
CoreData Research provides both business-to-business and business-to-consumer research, while the group’s offering includes market intelligence, guidance on strategic positioning, methods for developing new business, advice on operational marketing and other consulting services.
Our ability to produce tailored research that speaks to a client’s particular need is flexible and broad yet retains a specialist focus.
Camp Digital user experience and its influence on customer centricityNexer Digital
This talk will provide examples of some of the projects worked on at Blue Latitude for healthcare practitioners and patients and explore some of the issues presented when trying to be innovative in a highly regulated environment.
Access 2-healthcare company introduction deck - English - Apr 2019Access-2-Healthcare
Market Entry for Medical Technology / Medical Device companies, in Asia Pacific, Europe, US
Market Launch of medtech products
Convert non-medtech company to create medtech portfolio
Regulatory framework for government agencies
#Commercialisation
#Healthcare
#Regulatory
#government
#Quality
#SoftwareValidation
#Verification
#Manufacturing
#MedtechInnovation
#DueDiligence
#LicenseHolding
#Go-to-Market Strategy
#MarketStudies
#RegulatoryFramework
Crafting a Winning Product Innovation Strategy | Eninracseoeninrac
Elevate Your Product Innovation Strategy. We specialize in systematically identifying unmet customer needs and targeting growth opportunities in your market.
Redefining Growth Through Engagement DesignAlchemy Crew
This presentation has for purpose to provide Tech leaders, Investors, Established innovators with an overview on The Proposition Circle's approach to redefining and delivering unique customer engagements in highly disrupted and competitive markets.
Finding insights for our clients is our passion. The world is changing. In a world moving so quickly…. It’s easy to fall behind.
CoreData Research provides both business-to-business and business-to-consumer research, while the group’s offering includes market intelligence, guidance on strategic positioning, methods for developing new business, advice on operational marketing and other consulting services.
Our ability to produce tailored research that speaks to a client’s particular need is flexible and broad yet retains a specialist focus.
Camp Digital user experience and its influence on customer centricityNexer Digital
This talk will provide examples of some of the projects worked on at Blue Latitude for healthcare practitioners and patients and explore some of the issues presented when trying to be innovative in a highly regulated environment.
Access 2-healthcare company introduction deck - English - Apr 2019Access-2-Healthcare
Market Entry for Medical Technology / Medical Device companies, in Asia Pacific, Europe, US
Market Launch of medtech products
Convert non-medtech company to create medtech portfolio
Regulatory framework for government agencies
#Commercialisation
#Healthcare
#Regulatory
#government
#Quality
#SoftwareValidation
#Verification
#Manufacturing
#MedtechInnovation
#DueDiligence
#LicenseHolding
#Go-to-Market Strategy
#MarketStudies
#RegulatoryFramework
Crafting a Winning Product Innovation Strategy | Eninracseoeninrac
Elevate Your Product Innovation Strategy. We specialize in systematically identifying unmet customer needs and targeting growth opportunities in your market.
Redefining Growth Through Engagement DesignAlchemy Crew
This presentation has for purpose to provide Tech leaders, Investors, Established innovators with an overview on The Proposition Circle's approach to redefining and delivering unique customer engagements in highly disrupted and competitive markets.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Access 2-healthcare Company Introduction- English - Apr 2017
1. Where would you like to commercialise your healthcare product today?
Introducing
2. Access-2-Healthcare in a nutshell
Access-2-Healthcare helps medical technology companies gain market entry to various countries.
We execute and provide education on
• Market segment analysis and local market study
• In-country regulatory approvals, quality & trade compliance consulting
• Business due diligence - qualify business partners professionally, respectfully and objectively,
and can locally manage these business partners for you.
We support our execution with our software platforms and tools to encapsulate a unique,
comprehensive solution for your go-to-market desires.
Copyright Access-2-Healthcare 2
3. How did Access-2-Healthcare come about?
Our Origins
In love with the Healthcare industry, heeding the call for to make innovation available, and the drive
to contribute globally towards lowering overall healthcare costs, we created Access-2-Healthcare.
Our Vision
Enable access to healthcare globally, and contribute to lowering overall healthcare cost
Our Mission
Help medical technology partners gain market entry to provide people with safe, effective and
affordable healthcare around the world
Copyright Access-2-Healthcare 3
4. Our Company Culture - Education
Access-2-Healthcare believes in education,
empowerment, and competency development.
Even if it is far more challenging to achieve,
Education has the potential to reach more people
through knowledge sharing and networking.
This integrated approach helps us to ensure our
customers get all the necessary support they need
from every aspect of commercialisation.
Copyright Access-2-Healthcare 4
5. Our Company Culture - Work from home
In Access-2-Healthcare, our company
embraces the increasing need for
family time, personal space, and the
opportunity to work wherever,
whenever - to deliver the best
performance ever in a fun, relaxed
environment.
All team members work from home
or anywhere deemed safe by the
company, and appropriately enjoys
the same benefits as they would in
any other company.
Copyright Access-2-Healthcare 5
6. Our Core Competencies
▪ Market Entry
▪ Go-to-Market Strategy
▪ Regulatory Approvals
▪ Trade Compliance
▪ Business Due Diligence
▪ Quality Consulting
▪ Business partner performance management
▪ Software Tools that enable product commercialisation
Copyright Access-2-Healthcare 6
7. Concept Funding Prototype
Quality
Management
Systems
Design and
Development
Ready for
Manufacture
Going-to-
market
Regulatory
Approvals
Finding
distribution
channels
Product
reached
customers!
Product Commercialisation is Challenging
Copyright Access-2-Healthcare 7
8. Concept
Consulting - Value
Proposition, Market
Validation
Funding Prototype
Consulting - R&D,
Proof of Concept,
Intellectual Property
Quality
Management
Systems
Design and
Development
Mentorship / Consulting
Ready for
Manufacture
Going-to-
market
Regulatory
Approvals
Finding
distribution
channels
Product
reached
customers!
Research–to–Development Consulting
Copyright Access-2-Healthcare 8
9. Research–to-Development Consulting
Services
▪ Aid in developing proof of concept
▪ Aid in sourcing for funding
▪ Design and development consulting
Copyright Access-2-Healthcare 9
Client Company Size
small
small
small to medium
10. Concept Funding Prototype
Quality
Management
Systems
Establishment
Training / Assessment
Remediation
Design and
Development
Ready for
Manufacture
Going-to-
market
Regulatory
Approvals
Finding
distribution
channels
Product
reached
customers!
Quality Consulting
Organisations are finding ways to establish quick and
nimble quality systems to manufacture and/or market
medical technologies, and stay 100% compliant
Copyright Access-2-Healthcare 10
11. Quality Consulting
Services
Being inspection-ready for your Regulator or your Notified Body
Bespoke competence development for your organisation on all of
the quality topics
How to implement Quality Planning
Establish quality resourcing and infrastructural allocation
Integrating quality and risk management into your business
processes
Copyright Access-2-Healthcare 11
Client Company Size
All
All
All
medium to large
All
CAPA, Management Review, Complaint Handling, Audits, Training and
Development, Document and Records Management, Design Control, Process
Control, Process Validation, Supplier Management
We are part of the ISO committees that writes, revises and maintains the ISO13485
and ISO14971 standards. How more expert can you get?
12. Concept Funding Prototype
Quality
Management
Systems
Design and
Development
Ready for
Manufacture
Business Due Diligence
Going-to-
market
Regulatory
Approvals
Finding
distribution
channels
Product
reached
customers!
Qualify Business Partners and Manage Them Locally
Business Due Diligence
In country Business
Partner management
In country Business
Partner management
Copyright Access-2-Healthcare 12
13. Business Due Diligence
Services
▪ Business partner sourcing
▪ Business partner off-site background check
▪ Business partner audit and qualification
▪ Client specific in-house 4-day workshop
Copyright Access-2-Healthcare 13
Client Company Size
small to medium
small to medium
small to medium
medium to large
We check from top..
..to bottom!
14. Why Due Diligence?
▪ Despite attending trade exhibitions,
networking online or face-to-face,
business partnership appear to
depend on previous experience and
'feel' - is that the best way?
▪ Costs of re-establishing a business
partnership when the previous one
had failed, is a complex, lengthy, and
costly ordeal
▪ We minimise your business risks and
'restart costs'
▪ Maximises your chances of having a
positive, long-term relationship with
your business partner
Copyright Access-2-Healthcare 14
15. Concept Funding Prototype
Quality
Management
Systems
Design and
Development
Ready for
Manufacture
Going-to-
market
Regulatory
Approvals
Finding
distribution
channels
Product
reached
customers!
Go-to-Market Strategy
Market segment analysis
Local Market Study
Copyright Access-2-Healthcare 15
Market Validation
16. Our Solutions
We divide go-to-market strategy into two
levels to overcome market uncertainties:
Which market should you go to?
Analysis of current data combined with local
market data to identify and properly validate
the market segment
How do you make that market successful?
Specific local market studies performed by
local team members just for you. Target on
the expected users or key opinion leaders to
gain real local market insights
Your Results
The go-to-market strategy and processes
becomes more objective and structured.
You gain local knowledge on the market
tendencies, as well as customs, culture,
behaviours, that are critical to market
success
With the market validation, your product is
much more accepted when launched
The two step process potentially reduces
risk of un-necessary and excessive
investment – you save money $$$
Copyright Access-2-Healthcare 16
17. Concept Funding Prototype
Quality
Management
Systems
Design and
Development
Ready for
Manufacture
Going-to-
market
Regulatory
Approvals
Regulatory strategy
In country execution
Trade compliance consulting
Finding
distribution
channels
Product
reached
customers!
Regulatory Consulting
License holdingPost Market Surveillance
outsourcing
Copyright Access-2-Healthcare 17
18. Market Entry, Regulatory Consulting
Services
Product Registration - project-based or turnkey solutions
Training for product development teams on Regulatory Integration
Assessment and implementation of regulatory processes
Training and consulting on customs clearance through Trade Compliance
training courses
Copyright Access-2-Healthcare 18
Client Company Size
All
All
All
All
Regulatory approval capabilities in
Singapore, Malaysia, Indonesia, Philippines, Australia, China, Taiwan,
the EU, and the US
and sync with your supply chain team for trade compliance
19. Legal Entities - One Company, One Trusted Brand
▪ Access-2-Healthcare physically own company entities that are legally able to maintain
your product/import license for you.
▪ Wholly owned legal entities in Singapore, Malaysia, Thailand, Indonesia, Philippines,
Australia, Germany by end of 2017.
▪ Access-2-Healthcare uG (Germany) also a licensed European Union Authorised
Representative (EU AR), fully compliant to MDD 93/42 and EU MDR/IVDR, complete with
full post market surveillance capabilities
Distributor
A
Access-2-
Healthcare
Foreign
Manufacturer
Distributor
B
License holder
Distributor
A
Foreign
Manufacturer
Distributor
BLicense holder
Copyright Access-2-Healthcare 19
20. Concept
Consulting - Value
Proposition, Market
Validation
Funding Prototype
Consulting - R&D,
Proof of Concept,
Intellectual Property
Quality
Management
Systems
Establishment
Training / Assessment
Remediation
Design and
Development
Mentorship / Consulting
Ready for
Manufacture
Business Due Diligence
Going-to-
market
Regulatory
Approvals
Regulatory strategy
In country execution
Trade compliance consulting
Finding
distribution
channels
Product
reached
customers!
Present in Every Step of Product Commercialisation
Market segment analysis
Local Market Study
Business Due Diligence
In country Business
Partner management
In country Business
Partner management
License holding
Post Market Surveillance
outsourcing
Copyright Access-2-Healthcare 20
21. Software Tools to aid Commercialisation
Cost of Business Partnership Calculator
Have you ever wondered how much it actually can cost when
your company is trying to find a business partner to
commercialise in the market?
http://www.access2hc.com/soft-cost-of-business-partnership.html
Worldwide Regulatory Agency Websites
Can't seem to find a country regulatory authority's contact?
Here‘re their websites
http://www.access2hc.com/soft-resource-portal.html
Copyright Access-2-Healthcare 21
22. Commercialisation Tools - Partners Portal
An online platform that provides a NO-cost, low-risk option for sourcing and
connecting with prospective business partners
Accessible can be used and accessed anywhere in the world
Swift search function is quick and easy-to-use
Safe company details are only accessible by your connections
Relevant all users verified to be a registered company, in the healthcare industry
Key Features of Partners Portal
Copyright Access-2-Healthcare 22
http://partners.access2hc.com/
23. Commercialisation Tools - Secure Portal
One of the oft-forgotten, marginalised aspect within compliance is data security. We provide
a simple yet comprehensive solution to address the areas of data transfer that we believe to
be medium-high risk to a healthcare company. Simple. Swift. Secure. Secure Portal.
Coming Soon!
Key Features of Secure Portal
256-bit encrypted, 2-factor authentication file transfer
web application for your confidential documentation.
Closed system, FDA CFR Part 11 capable, with the
necessary anti-virus scan and storage backup
Copyright Access-2-Healthcare 23
